PeptideStack
5.2kquestions
20kanswers
220users

Is a 99.1% result from Janoshik comparable to 96.8% from Medutest?

Asked 18 Nov 2024Modified 20 months agoViewed 31k times
This question was marked as a duplicate of Is a 99.4% result from Janoshik comparable to 98.2% from Medutest?Closed 9 Dec 2024. It remains here because the answers below are specific to how it was asked.
32

What I have: 99.1% · Janoshik · 96.8% · Medutest.

I want to know what the trade-off actually is rather than which option is fashionable.

I would rather have a defensible reason than a marginal improvement.

What does each option buy me, and what does it cost me?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questionsreference-standard
reference-standard

Certified reference materials and in-house standards: traceability, the certificate of the standard itself, system suitability, and why every…

179 questions
shareeditfollowflag
JV
askedjo_vandeberg19k2718 Nov 2024

No answers yet

This question has not been answered. It has been viewed 31k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.